allogeneic natural killer cells

Cell therapyexperimental

Natural killer cells, also known as NK cells, are a type of cytotoxic lymphocyte critical to the innate immune system. They are a kind of large granular lymphocyte (LGL), belong to the rapidly expanding family of known innate lymphoid cells (ILC), and represent 5–20% of all circulating lymphocytes in humans. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cells, stressed cells, tumor cells, and other intracellular pathogens based on signals from several activating and inhibitory receptors. Most immune cells detect the antigen presented on major histocompatibility complex I (MHC-I) on infected cell surfaces, but NK cells can recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class I. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells. — Wikipedia

Clinical trial activity

141 trials · 116 clinical orgs · 0 marketing orgs

Phase 1
97
Phase 2
83
Phase 3
3
Phase 4
0

Earliest trial started Jul 1, 2001 (NCT01220544)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2007

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Unspecified targetImmunity, passive

    immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • allogeneic natural killer cells
  • allogeneic nk cells
  • allogenic nk cells
  • donor natural killer cell
  • donor natural killer cells
  • donor nk cell
  • expanded haploidentical natural killer cells
  • expanded nk cells
  • haploidentical donor derived natural killer cell
  • haploidentical natural killer cell
  • haploidentical nk cell
  • haploidentical nk cells
  • immune killer cells
  • natural killer cell
  • natural killer cells
  • nk cell
  • nk cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07247201Phase 1/Phase 2 (Phase 2)Jan 31, 2026Singapore General Hospital
NCT07225439Phase 1Dec 31, 2025Case Western Reserve University, Incyte
NCT07230574Phase 2Nov 30, 2025Anhui Medical University, Nanjing University, Soochow University, University of Science and Technology of China, Zhejiang University
NCT06991114Phase 2Jul 9, 2025Artiva Biotherapeutics, Inc.
NCT07259889Phase 1Jun 16, 2025Chinese Academy of Medical Sciences, Government of China
NCT07044050Phase 1Jun 10, 2025Emmecell
NCT07256210Phase 2May 9, 2025Federal Research Institute of Pediatric Hematology, Oncology and Immunology
NCT06751134Phase 1Dec 28, 2024Nanjing Medical University
NCT06750133Phase 1Dec 14, 2024Zhejiang University
NCT06641648Phase 1Dec 1, 2024Peking University
NCT06674265Phase 1Nov 30, 2024Iran University of Medical Sciences, Kian Immune Cell Company, Royan Institute
NCT06730009Phase 1/Phase 2 (Phase 2)Oct 21, 2024Medigen Biotechnology Corporation
NCT06568328Phase 1Sep 1, 2024Fujian Medical University
NCT06158828Phase 1/Phase 2 (Phase 2)Mar 31, 2024Rising Tide Foundation, The Leukemia and Lymphoma Society, Washington University in St. Louis
NCT06245018N/AFeb 1, 2024Nuwacell Biotechnologies Co., Ltd.
NCT05990920Phase 1Aug 23, 2023NKGen Biotech, Inc.
NCT05987696Phase 1Aug 10, 2023China Academy of Chinese Medical Sciences, Hangzhou Qihan Biotech Co.,Ltd.
NCT05976906Phase 1May 23, 2023Zhejiang University
NCT05744440Early Phase 1 (Phase 1)Mar 1, 2023Xuzhou Medical University
NCT05629546Phase 1Feb 28, 2023Washington University in St. Louis
Showing 20 of 141 trials
Page 1 / 8

Organizations

Research & Development (116)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of Texas at HoustonAcademic/Hospital161422006
National Cancer Institute (NCI)Government13422006
University of MinnesotaAcademic/Hospital131222005
Jinan UniversityAcademic/Hospital101012016
Shenzhen Hank Bioengineering InstituteGovernment10012016
St. Jude Children's HospitalAcademic/Hospital8832003
National University of SingaporeAcademic/Hospital5522007
Ohio State UniversityAcademic/Hospital5432015
Ivy Life Sciences, Co., LtdFor profit4332005
University of UlsanAcademic/Hospital4422009
Zhejiang UniversityAcademic/Hospital4322021
Assisi FoundationAcademic/Hospital3022007
Case Western Reserve UniversityAcademic/Hospital3312017
CelgeneFor profit3022013
Cornell UniversityAcademic/Hospital3322007
Government of TaiwanGovernment3022009
The Leukemia and Lymphoma SocietyAcademic/Hospital3022014
Universidad Autonoma de MadridAcademic/Hospital3112013
University of WashingtonAcademic/Hospital3212006
Washington University in St. LouisAcademic/Hospital3322017
116 organizations
Page 1 / 6